Taiwan FDA registration 95ab940986193d61ea302c0087ea2289

"Baiyou Jingya" Influenza Virus A+B Rapid Test Reagent (Unsterilized)

TW: "百優耐析雅" 流感病毒A+B快速檢測試劑 (未滅菌)

Taiwan·Risk Class 1·BIOMERIEUX (SHANGHAI) BIOTECH CO., LTD.·Registered Aug 25, 2011 – Aug 25, 2021Cancelled

Registration details

Analysis ID: 95ab940986193d61ea302c0087ea2289
Customs Code: DHA04600144908

Company information

Manufacturer: BIOMERIEUX (SHANGHAI) BIOTECH CO., LTD.
Manufacturer Country: China
Authorized Representative: Hong Kong Commercial Mérieux S.p.A. Taiwan Branch

Product details

Intended Use: Limited to the first level identification range of the Measures for the Administration of Medical Devices "Influenza Virus Serum Reagent (C.3330)".
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3330 流感病毒血清試劑
Import Information: Chinese goods;; input

Dates and status

Registration Date: Aug 25, 2011
Expiry Date: Aug 25, 2021
Cancellation Date: Sep 08, 2023

Cancellation information

Status: Logged out
Reason: 未展延而逾期者

About this record

Access comprehensive regulatory information for "Baiyou Jingya" Influenza Virus A+B Rapid Test Reagent (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 95ab940986193d61ea302c0087ea2289 and manufactured by BIOMERIEUX (SHANGHAI) BIOTECH CO., LTD.. The authorized representative in Taiwan is Hong Kong Commercial Mérieux S.p.A. Taiwan Branch.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.